Klebe S - Search Results

1

Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer.

Pavlakis N, Cooper C, John T, Kao S, Klebe S, Lee CK, Leong T, Millward M, O'Byrne K, Russell PA, Solomon B, Cooper WA, Fox S. Pavlakis N, et al. Among authors: klebe s. Pathology. 2019 Dec;51(7):673-680. doi: 10.1016/j.pathol.2019.08.006. Epub 2019 Oct 24. Pathology. 2019. PMID: 31668406 Review.

2

Validation of tissue microarray technology in malignant pleural mesothelioma.

Kao SC, Lee K, Armstrong NJ, Clarke S, Vardy J, van Zandwijk N, Reid G, Burn J, McCaughan BC, Henderson DW, Klebe S. Kao SC, et al. Among authors: klebe s. Pathology. 2011 Feb;43(2):128-32. doi: 10.1097/PAT.0b013e328342016c. Pathology. 2011. PMID: 21233673

3

Molecular biomarkers in malignant mesothelioma: state of the art.

Kao SC, Reid G, van Zandwijk N, Henderson DW, Klebe S. Kao SC, et al. Among authors: klebe s. Pathology. 2011 Apr;43(3):201-12. doi: 10.1097/PAT.0b013e3283445e67. Pathology. 2011. PMID: 21436629 Review.

4

Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma.

Kao SC, Griggs K, Lee K, Armstrong N, Clarke S, Vardy J, van Zandwijk N, Burn J, McCaughan BC, Henderson DW, Klebe S. Kao SC, et al. Among authors: klebe s. Pathology. 2011 Jun;43(4):313-7. doi: 10.1097/PAT.0b013e32834642da. Pathology. 2011. PMID: 21532523

5

Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: trends in Australia and a literature review.

Linton A, Kao S, Vardy J, Clarke S, van Zandwijk N, Klebe S. Linton A, et al. Among authors: klebe s. Asia Pac J Clin Oncol. 2013 Sep;9(3):273-9. doi: 10.1111/ajco.12043. Epub 2012 Nov 21. Asia Pac J Clin Oncol. 2013. PMID: 23167246 Review.

6

Facts and fiction: premalignant lesions of lung tissues.

Klebe S, Henderson DW. Klebe S, et al. Pathology. 2013 Apr;45(3):305-15. doi: 10.1097/PAT.0b013e32835f45fd. Pathology. 2013. PMID: 23448809 Review.

7

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.

Henderson DW, Reid G, Kao SC, van Zandwijk N, Klebe S. Henderson DW, et al. Among authors: klebe s. J Clin Pathol. 2013 Oct;66(10):847-53. doi: 10.1136/jclinpath-2012-201303. Epub 2013 Jun 27. J Clin Pathol. 2013. PMID: 23814259 Review.

8

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.

Henderson DW, Reid G, Kao SC, van Zandwijk N, Klebe S. Henderson DW, et al. Among authors: klebe s. J Clin Pathol. 2013 Oct;66(10):854-61. doi: 10.1136/jclinpath-2013-201609. Epub 2013 Jul 6. J Clin Pathol. 2013. PMID: 23833051 Review.

9

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.

Hudson AL, Weir C, Moon E, Harvie R, Klebe S, Clarke SJ, Pavlakis N, Howell VM. Hudson AL, et al. Among authors: klebe s. Sci Rep. 2014 Aug 21;4:6152. doi: 10.1038/srep06152. Sci Rep. 2014. PMID: 25141917 Free PMC article.

10

MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.

Kirschner MB, Cheng YY, Armstrong NJ, Lin RC, Kao SC, Linton A, Klebe S, McCaughan BC, van Zandwijk N, Reid G. Kirschner MB, et al. Among authors: klebe s. Mol Oncol. 2015 Mar;9(3):715-26. doi: 10.1016/j.molonc.2014.11.007. Epub 2014 Dec 2. Mol Oncol. 2015. PMID: 25497279 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters